Nuveen LLC Purchases Shares of 149,431 Integer Holdings Corporation $ITGR

Key Points

• Nuveen LLC has acquired 149,431 shares of Integer Holdings Corporation, investing approximately $17.6 million, representing 0.43% of the company's stock as of the latest SEC filing.
• Various institutional investors, including Congress Asset Management Co. and Bamco Inc. NY, have increased their stakes in Integer, reflecting a positive sentiment as 99.29% of the stock is owned by such entities.
• Integer recently reported quarterly earnings of $1.55 per share, slightly missing analyst estimates, but revenue increased by 11.4% year-over-year, leading to an expected earnings per share of $6.01 for the current year.

Nuveen LLC bought a new stake in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 149,431 shares of the medical equipment provider's stock, valued at approximately $17,634,000. Nuveen LLC owned about 0.43% of Integer as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of ITGR. AdvisorNet Financial Inc bought a new position in Integer during the 1st quarter valued at $28,000. Opal Wealth Advisors LLC bought a new position in shares of Integer during the first quarter valued at about $28,000. Bessemer Group Inc. boosted its holdings in Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 125 shares during the last quarter. Sterling Capital Management LLC grew its position in Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after purchasing an additional 279 shares in the last quarter. Finally, Headlands Technologies LLC grew its position in Integer by 1,234.8% in the 1st quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider's stock worth $145,000 after purchasing an additional 1,136 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Performance

ITGR stock traded up $3.8190 during midday trading on Friday, reaching $110.6490. 256,433 shares of the company's stock traded hands, compared to its average volume of 373,536. The firm has a market capitalization of $3.88 billion, a PE ratio of 48.74, a price-to-earnings-growth ratio of 0.84 and a beta of 1.02. The company has a 50-day moving average price of $113.76 and a two-hundred day moving average price of $119.20. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.02). The company had revenue of $476.00 million during the quarter, compared to analysts' expectations of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. Integer's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, equities analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current year.

Insider Activity

In other news, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $120.56, for a total value of $1,051,283.20. Following the sale, the director directly owned 22,170 shares of the company's stock, valued at approximately $2,672,815.20. This represents a 28.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Donald J. Spence sold 14,739 shares of the business's stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the transaction, the director directly owned 18,781 shares of the company's stock, valued at approximately $2,260,856.78. This represents a 43.97% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.16% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on ITGR. Raymond James Financial cut their target price on Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research note on Friday, July 25th. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and boosted their price objective for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Wells Fargo & Company lowered their target price on Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Finally, Benchmark cut their price target on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $140.25.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.